These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 11768626)

  • 21. Neuroprotective effect of silymarin in a MPTP mouse model of Parkinson's disease.
    Pérez-H J; Carrillo-S C; García E; Ruiz-Mar G; Pérez-Tamayo R; Chavarría A
    Toxicology; 2014 May; 319():38-43. PubMed ID: 24607817
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mice deficient in TNF receptors are protected against dopaminergic neurotoxicity: implications for Parkinson's disease.
    Sriram K; Matheson JM; Benkovic SA; Miller DB; Luster MI; O'Callaghan JP
    FASEB J; 2002 Sep; 16(11):1474-6. PubMed ID: 12205053
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MPTP-induced dopaminergic degeneration and deficits in object recognition in rats are accompanied by neuroinflammation in the hippocampus.
    Sy HN; Wu SL; Wang WF; Chen CH; Huang YT; Liou YM; Chiou CS; Pawlak CR; Ho YJ
    Pharmacol Biochem Behav; 2010 Apr; 95(2):158-65. PubMed ID: 20064549
    [TBL] [Abstract][Full Text] [Related]  

  • 24. (1)H NMR-based metabolomics study on a goldfish model of Parkinson's disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
    Lu Z; Wang J; Li M; Liu Q; Wei D; Yang M; Kong L
    Chem Biol Interact; 2014 Nov; 223():18-26. PubMed ID: 25242684
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Social enrichment attenuates nigrostriatal lesioning and reverses motor impairment in a progressive 1-methyl-2-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease.
    Goldberg NR; Fields V; Pflibsen L; Salvatore MF; Meshul CK
    Neurobiol Dis; 2012 Mar; 45(3):1051-67. PubMed ID: 22198503
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The potentiating effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on paraquat-induced neurochemical and behavioral changes in mice.
    Shepherd KR; Lee ES; Schmued L; Jiao Y; Ali SF; Oriaku ET; Lamango NS; Soliman KF; Charlton CG
    Pharmacol Biochem Behav; 2006 Mar; 83(3):349-59. PubMed ID: 16580056
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PPAR-α agonist fenofibrate protects against the damaging effects of MPTP in a rat model of Parkinson's disease.
    Barbiero JK; Santiago R; Tonin FS; Boschen S; da Silva LM; Werner MF; da Cunha C; Lima MM; Vital MA
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Aug; 53():35-44. PubMed ID: 24593945
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gene dysregulation is restored in the Parkinson's disease MPTP neurotoxic mice model upon treatment of the therapeutic drug Cu(II)(atsm).
    Cheng L; Quek CY; Hung LW; Sharples RA; Sherratt NA; Barnham KJ; Hill AF
    Sci Rep; 2016 Mar; 6():22398. PubMed ID: 26928495
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The actions of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in animals as a model of Parkinson's disease.
    Jenner P; Marsden CD
    J Neural Transm Suppl; 1986; 20():11-39. PubMed ID: 3091760
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Animal models of Parkinson's disease: an empirical comparison with the phenomenology of the disease in man.
    Gerlach M; Riederer P
    J Neural Transm (Vienna); 1996; 103(8-9):987-1041. PubMed ID: 9013391
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Validity of the MPTP-Treated Mouse as a Model for Parkinson's Disease.
    Klemann CJHM; Martens GJM; Poelmans G; Visser JE
    Mol Neurobiol; 2016 Apr; 53(3):1625-1636. PubMed ID: 25676140
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pain perception in acute model mice of Parkinson's disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
    Park J; Lim CS; Seo H; Park CA; Zhuo M; Kaang BK; Lee K
    Mol Pain; 2015 May; 11():28. PubMed ID: 25981600
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanisms of MPTP toxicity and their implications for therapy of Parkinson's disease.
    Watanabe Y; Himeda T; Araki T
    Med Sci Monit; 2005 Jan; 11(1):RA17-23. PubMed ID: 15614202
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dangguijakyak-san protects dopamine neurons against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity under postmenopausal conditions.
    Lee JM; Hwang DS; Kim HG; Lee CH; Oh MS
    J Ethnopharmacol; 2012 Feb; 139(3):883-8. PubMed ID: 22178176
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of the root bark of Paeonia suffruticosa on mitochondria-mediated neuroprotection in an MPTP-induced model of Parkinson's disease.
    Kim HG; Park G; Piao Y; Kang MS; Pak YK; Hong SP; Oh MS
    Food Chem Toxicol; 2014 Mar; 65():293-300. PubMed ID: 24389454
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Geraniol attenuates α-synuclein expression and neuromuscular impairment through increase dopamine content in MPTP intoxicated mice by dose dependent manner.
    Rekha KR; Selvakumar GP; Santha K; Inmozhi Sivakamasundari R
    Biochem Biophys Res Commun; 2013 Nov; 440(4):664-70. PubMed ID: 24103762
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-lasting reactive changes observed in microglia in the striatal and substantia nigral of mice after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Yasuda Y; Shinagawa R; Yamada M; Mori T; Tateishi N; Fujita S
    Brain Res; 2007 Mar; 1138():196-202. PubMed ID: 17275793
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of metabolic changes in the striatum of a MPTP-intoxicated canine model: in vivo ¹H-MRS study of an animal model for Parkinson's disease.
    Choi CB; Kim SY; Lee SH; Jahng GH; Kim HY; Choe BY; Ryu KN; Yang DM; Yim SV; Choi WS
    Magn Reson Imaging; 2011 Jan; 29(1):32-9. PubMed ID: 20980117
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The MPTP neurotoxic lesion model of Parkinson's disease activates the apolipoprotein E cascade in the mouse brain.
    Domenger D; Dea D; Theroux L; Moquin L; Gratton A; Poirier J
    Exp Neurol; 2012 Jan; 233(1):513-22. PubMed ID: 22155743
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of iron in Parkinson disease and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity.
    Yantiri F; Andersen JK
    IUBMB Life; 1999 Aug; 48(2):139-41. PubMed ID: 10794588
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.